Researchers discover way to inhibit major cancer gene

(University of Illinois at Chicago) Researchers at the University of Illinois at Chicago have identified a new way to block the action of genetic mutations found in nearly 30 percent of all cancers. John O'Bryan, associate professor of pharmacology in the UIC College of Medicine, and a team of researchers discovered that a synthetic binding protein they call 'NS1 monobody,' which they created in the lab, can block the activity of the RAS proteins.